Paragon Capital Management (Kansas)’s Novartis NVS Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-71	Closed	-$6K	–	129
2020 Q1	$6K	Buy	+71	New	+$6.33K	﹤0.01%	158
2019 Q3	–	Sell	-259	Closed	-$24K	–	162
2019 Q2	$24K	Buy	259 +202	+354%	+$17.1K	0.01%	122
2019 Q1	$5K	Buy	+57	New	+$4.58K	﹤0.01%	198

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Paragon Capital Management (Kansas)'s NVS Position: Q2 2020 in Review

Paragon Capital Management (Kansas) sold out of Novartis (NVS) in Q2 2020, closing a stake of 71 shares — an estimated $6K sold.

Paragon Capital Management (Kansas) first reported a position in NVS in Q1 2019 and held it in 3 quarters. The position peaked at $24K in Q2 2019. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Paragon Capital Management (Kansas) reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Paragon Capital Management (Kansas) sold 71 Novartis shares in Q2 2020, an estimated $6K.
Paragon Capital Management (Kansas) first reported a position in Novartis in Q1 2019 and held it in 3 quarters.
Paragon Capital Management (Kansas)'s Novartis position peaked at $24K in Q2 2019.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2020, filed 3 Aug 2020.